Abstract
Efficiently scouting the chemical space is one of the major challenges for lead discovery for drug development. In recent times some shifts have been made away from HTS and combinatorial chemistry to more focused approaches. Combinatorial chemistry was the starting point for the development of synthesis concepts that were intended to cover and explore the chemical space without having to prepare every individual compound. In this review, these lead finding approaches will be discussed comparing virtual and synthesized libraries. In addition we discuss the concepts and relationships of evolutionary libraries using genetic algorithms and dynamic combinatorial chemistries, as well as templated fragment ligation concepts. Taking a more abstract view of all approaches, the concepts may loop back into Combinatorial Chemistry allowing a more educated choice of building blocks and chemistries.
Keywords: pharmacological screening, genomic, high-throughput identification, drug discovery, mass spectrometry, oligonucleotides, combinatorial synthesis, mrna, dynamic combinatorial library, thermodynamics
Current Drug Discovery Technologies
Title: Combinatorial Chemistry and Fragment Screening - Two Unlike Siblings?
Volume: 2 Issue: 1
Author(s): Hans Peter Nestler
Affiliation:
Keywords: pharmacological screening, genomic, high-throughput identification, drug discovery, mass spectrometry, oligonucleotides, combinatorial synthesis, mrna, dynamic combinatorial library, thermodynamics
Abstract: Efficiently scouting the chemical space is one of the major challenges for lead discovery for drug development. In recent times some shifts have been made away from HTS and combinatorial chemistry to more focused approaches. Combinatorial chemistry was the starting point for the development of synthesis concepts that were intended to cover and explore the chemical space without having to prepare every individual compound. In this review, these lead finding approaches will be discussed comparing virtual and synthesized libraries. In addition we discuss the concepts and relationships of evolutionary libraries using genetic algorithms and dynamic combinatorial chemistries, as well as templated fragment ligation concepts. Taking a more abstract view of all approaches, the concepts may loop back into Combinatorial Chemistry allowing a more educated choice of building blocks and chemistries.
Export Options
About this article
Cite this article as:
Nestler Peter Hans, Combinatorial Chemistry and Fragment Screening - Two Unlike Siblings?, Current Drug Discovery Technologies 2005; 2 (1) . https://dx.doi.org/10.2174/1570163053175484
DOI https://dx.doi.org/10.2174/1570163053175484 |
Print ISSN 1570-1638 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6220 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
NAD(P) Biosynthesis Enzymes as Potential Targets for Selective Drug Design
Current Medicinal Chemistry Azole Antimycotics - A Highway to New Drugs or a Dead End?
Current Medicinal Chemistry Psychosocial Vulnerability and Early Life Adversity as Risk Factors for Central Sensitivity Syndromes
Current Rheumatology Reviews Yeast Genomics and Drug Target Identification
Combinatorial Chemistry & High Throughput Screening Modulating Poly (ADP-Ribose) Polymerase Activity: Potential for the Prevention and Therapy of Pathogenic Situations Involving DNA Damage and Oxidative Stress
Current Pharmaceutical Biotechnology The Antioxidant Response Element and Oxidative Stress Modifiers in Airway Diseases
Current Molecular Medicine Modulation of Carbonic Anhydrase 9 (CA9) in Human Brain Cancer
Current Pharmaceutical Design Structural and Pharmacological Features of Phospholipases A2 from Snake Venoms
Protein & Peptide Letters Applications of High Content Screening in Life Science Research
Combinatorial Chemistry & High Throughput Screening Review: Therapeutic Targeting of HMGB1 in Stroke
Current Drug Delivery Analytical and Pharmacological Aspects of Therapeutic Drug Monitoring of mTOR Inhibitors
Current Drug Metabolism miR-21, An Oncogenic Target miRNA for Cancer Therapy: Molecular Mechanisms and Recent Advancements in Chemo and Radio-resistance
Current Gene Therapy 5-Benzylidene-3,4-dihalo-furan-2-one derivatives inhibit human leukemia cancer cells through suppression of NF-κB and GSK-3β
Anti-Cancer Agents in Medicinal Chemistry Blood Pressure Variability/Dipper/Non-dipper in Hypertension and Diabetes
Current Hypertension Reviews Amyloid Beta Protein as a Marker or Risk Factor of Alzheimers Disease
Current Alzheimer Research Platelets: Angels and Demons Dancing on the Immune Stage. Nutrition Conducts the Orchestra
Endocrine, Metabolic & Immune Disorders - Drug Targets Shoulder Manifestations of Diabetes Mellitus
Current Diabetes Reviews Current Drug Discovery for Anti-hepatitis C Virus Targeting NS4B
Current Topics in Medicinal Chemistry Evaluation of Novel 7-(hetero)aryl-substituted Pyrazolo[1, 5-a]pyrimidines as Phosphodiesterase-4 Inhibitors
Letters in Drug Design & Discovery Regulation of Drug Metabolism and Transporters
Current Drug Metabolism